Diurnal variation and age differences in the biochemical markers of bone turnover in horses

Journal of Animal Science

Volumn 77, Issue 1, 1999, Pages 75-83

  Black, A ^b   Schoknecht, P A ^b   Ralston, S L ^b   Shapses, S A ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NONE

Author keywords

Age; Bone Formation; Diurnal Variation; Horses; Osteocalcin

Indexed keywords

EQUIDAE; EQUUS CABALLUS;

AMINO ACID; BIOLOGICAL MARKER; DEOXYPYRIDINOLINE; HYDROCORTISONE; OSTEOCALCIN; PYRIDINOLINE;

AGING; ANIMAL; ARTICLE; BLOOD; BONE REMODELING; CIRCADIAN RHYTHM; HORSE; MALE; PHYSIOLOGY; URINE;

AGING; AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; BONE REMODELING; CIRCADIAN RHYTHM; HORSES; HYDROCORTISONE; MALE; OSTEOCALCIN;

EID: 0032616249     PISSN: 00218812     EISSN: None     Source Type: Journal    
DOI: 10.2527/1999.77175x     Document Type: Article

References (53)

1. Beardsworth, L. J., D. R. Eyre, and I. R. Dickson. 1990. Changes with age in the urinary excretion of lysyl-and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J. Bone Miner. Res. 5:671-676.
2. Black, A., S. L. Ralston, S. A. Shapses, L. S. Suslak-Brown, and P. A. Schoknecht. 1997. Skeletal growth patterns in Standardbred foals from birth to one year. Proc. 15th Equine Nutr. Physiol. Symp., Fort Worth, TX. 15:326(Abstr.).
3. Black, D., A. Duncan, and S. P. Robins. 1988. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ionpaired reversed-phase high-performance liquid chromatography. Anal. Biochem. 169:197-203.
4. Bollen, A.-M., and D. R. Eyre. 1994. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone 15:31-34.
5. Bottoms, G. D., O. F. Roesel, F. D. Rausch, and E. L. Akins. 1972. Circadian variation in plasma cortisol and cortisosterone levels in pigs and mares. Am. J. Vet. Res. 33:785-790.
6. Calvo, M. S., D. R. Eyre, and C. M. Gundberg. 1996. Molecular basis and clinical application of biological markers of bone turnover. Endocr. Rev. 17:333-367.
7. Davicco, M. J., Y. Faulconnier, V. Coxam, H. Dubroeucq, W. Martin-Rosset, and J. P. Barley. 1994. Arch. Int. Physiol. Biochim. Biophys. 102:115-119.
8. Delmas, P. D., L. Malaval, M. E. Arlot, and P. J. Meunier. 1985. Serum bone gla-protein compared to bone histomorphometry in endocrine diseases. Bone 6:339-341.
9. Eastell, R., M. S. Calvo, M. F. Burritt, K. P. Offord, R.G.G. Russell, and B. L. Riggs. 1992a. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J. Clin. Endocrinol. Metab. 74:487-494.
10. Eastell, R., P. S. Simmons, A. Colwell, A.M.A. Assiri, M. F. Burritts, R.G.G. Russell, and B. L. Riggs. 1992b. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: Effects of growth and aging. Clin. Sci. 83:375-382.
11. Eyre, D. R., T. J. Koob, and K. P. Van Ness. 1984. Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography. Anal. Biochem. 137:380-388.
12. Fujimoto, S., K. Toshihide, H. Tanaka, M. Miura, and Y. Seino. 1995. Urinary pyridinoline and deoxypyridinoline in healthy children with growth hormone deficiency. J. Clin. Endocrinol. Metab. 80:1922-1929.
13. Garnero, P., and P. D. Delmas. 1996. Measurements of biochemical markers: Methods and limitations. In: J. P. Bilezikian, L. G. Raisz, and G. A. Rodan (Ed.) Principles of Bone Biology. pp 1277-1291. Academic Press, San Diego, CA.
14. Garnero, P., E. Gineyts, J. P. Riou, and P. D. Delmas. 1994. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J. Clin. Endocrinol. Metab. 79:780-785.
15. Geddes, A. D. 1996. Animal models of bone disease. In: J. P. Bilezikian, L. G. Raisz, and G. A. Rodan (Ed.) Principles of Bone Biology. pp 1343-1354. Academic Press, San Diego, CA.
16. Geor, R., E. Hope, L. Lauper, S. Piela, J. Klassen, V. King, and M. Murphy. 1995. Effect of glucocortocoids on serum osteocalcin concentration in horses. Am. J. Vet. Res. 56:1201-1205.
17. Gundberg, C. M., J. B. Lian, and P. M. Gallop. 1983. Measurements of y-carboxyglutamate and circulating osteocalcin in normal children and adults. Clin. Chim. Acta 128:1-8.
18. Gundberg, C. M., M. E. Markowitz, M. Mizruchi, and J. F. Rosen. 1985. Osteocalcin in human serum: A circadian rhythm. J. Clin. Endocrinol. Metab. 60:736-739.
19. Heshmati, H. M., B. L. Riggs, M. F. Burrit, C. A. McAlister, P. C. Wollan, and S. Khosla. 1998. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women. J. Clin. Endocrinol. Metab. 83:751-756.
20. Hope, E., S. D. Johnston, R. L. Hegstad, R. J. Geor, and M. J. Murphy. 1993. Effects of sample collection and handling on concentration of osteocalcin in equine serum. Am. J. Vet. Res. 54:1017-1020.
21. Johansen, J. S., D. H. Giwercman, C. T. Nielsen, P. A. Price, C. Christiansen, and N. E. Skakkebaer. 1988. Serum bone glaprotein as a marker of bone growth in children and adolescents: Correlation with age, height, serum insulin-like growth factor I, and serum testosterone. J. Clin. Endocrinol. Metab. 67: 273-278.
22. Johnson, A. L., and K. Malinowski. 1986. Daily rhythm of cortisol, and evidence for a photo-inducible phase for prolactin secretion in nonpregnant mares housed under noninterrupted and skeleton photoperiods. J. Anim. Sci. 63:169-175.
23. Komosa, M., A. Flisinska-Bojanowska, and J. Gill. 1990. Development of diurnal rhythm in some metabolic parameters in foals. Comp. Biochem. Physiol. 95A:549-552.
24. Lakatos, P., A. Blumsohn, R. Eastell, G. Tarjan, H. Shinoda, and P. H. Stern. 1995. Circadian rhythm of in vitro bone-resorbing activity in human serum. J. Clin. Endocrinol. Metab. 8: 3185-3190.
25. Lepage, O. M., L. DesCoteaux, M. Marcoux, and A. Trembly. 1991. Circadian rhythms of osteocalcin in equine serum. Correlation with alkaline phosphatase, calcium, phosphate and total protein levels. Can. J. Vet. Res. 55:5-8.
26. Lepage, O. M., S. Laverty, M. Marcoux, and G. Dumas. 1993. Serum osteocalcin concentration in horses treated with triamcinolone acetonide. Am. J. Vet. Res. 54:1209-1212.
27. Lepage, O. M., M. Marcoux, and A. Tremblay. 1990. Serum osteocalcin of bone Gla-protein, a biochemical marker for bone metabolism in horses: Differences in serum levels with age. Can. J. Vet. Res. 54:223-226.
28. Lepage, O. M., M. Marcoux, A. Tremblay, and G. Dumas. 1992. Sex does not influence serum osteocalcin levels in Standardbred horses of different ages. Can. J. Vet. Res. 56:379-381.
29. Lieuw-A-Fa, M., R. Sierra, and B. L. Specker. 1995. Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age. J. Bone Miner. Res. 10:849-853.
30. Lutchman, L., T. Hardwick, R. Biener, R. J. Trout, and S. A. Shapses. 1998. Longitudinal study of urinary hydroxypyridinium cross-links and growth in healthy infants: Higher values with breastfeeding. Exp. Clin. Endocrinol. Diabetes 106: 51-56.
31. Maenpaa, P. H., A. Pirskanen, and E. Koskinen. 1988. Biochemical indicators of bone formation in foals after transfer from pasture to stables for the winter months. Am. J. Vet. Res. 49: 1990-1992.
32. Malinowski, K., N. A. Hallquist, L. Helyar, A. R. Sherman, and C. G. Scanes. 1990. Effect of different separation protocols between mares and foals on plasma cortisol and cell-mediated immune response. J. Equine Vet. Sci. 10:363-368.
33. Markowitz, M. E., C. M. Gundberg, and J. F. Rosen. 1987. The circadian rhythm of serum osteocalcin concentrations: Effects of 1,25 dihydroxyvitamin D administration. Calcif. Tissue Int. 40:179-183.
34. Marks. S. C., and D. C. Hermey. 1996. The structure and development of bone. In: J. P. Bilezikian, L. G. Raisz, and G. H. Rodan (Ed.) Principles of Bone Biology. pp 3-14. Academic Press, San Diego, CA.
35. Nielsen, H. K. 1994. Circadian and circatrigentan changes in osteoblastic activity assessed by serum osteocalcin. Dan. Med. Bull. 41:216-227.
36. Nielsen, K. H., K. Brixen, M. Kassem, P. Charles, and L. Mosekilde. 1992. Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: Evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin. J. Clin. Endocrinol. Metab. 74:1410-1414.
37. Nielsen, K. H., K. Brixen, M. Kassem, S. E. Christensen, and L. Mosekilde. 1991a. Diurnal rhythm in serum osteocalcin: Relation with sleep, growth hormones, and PTH(1-84). Calcif. Tissue Int. 49:373-377.
38. Nielsen, K. H., K. Brixen, and L. Mosekilde. 1990. Diurnal Rhythm and 24-hour integrated concentrations of serum osteocalcin in normals: Influence of age, sex, season, and smoking habits. Calcif. Tissue Int. 47:284-290.
39. Nielsen, K. H., P. Laurberg, K. Brixon, and L. Mosekilde. 1991b. Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone, and ionized calcium in normal individuals. Acta Endocrinol. 124:391-398.
40. Patterson-Allen, P., C. E. Brautigham, R. E. Grindeland, C. W. Asling, and P. X. Callahan. 1982. A specific radioimmunoassay for osteocalcin with advantageous species crossreactivity. Anal. Biochem. 120:1-7.
41. Price, J., A. Colewell, R. Eastell, A. E. Goodship, and R.G.G. Russell. 1992. Urinary excretion of deoxypyridinoline as a marker of bone resorption in the thoroughbred racehorse. Bone 13: 279(Abstr.).
42. Price, J. S., B. Jackson, R. Eastell, A. E. Goodship, A. Blumsohn, I. Wright, S. Stoneham, L. E. Lanyon, and R.G.G. Russell. 1995a. Age related changes in biochemical markers of bone metabolism in horses. Equine Vet. J. 27:201-207.
43. Price, J. S., B. Jackson, R. Eastell, A. M. Wilson, R.G.G. Russell, L. L. Lanyon, and A. E. Goodship. 1995b. The response of the skeleton to physical training: A biochemical study in horses. Bone 17:221-227.
44. Price, P. A., J. G. Parthemore, and L. J. Deftos. 1980. New biochemical marker for bone metabolism. Measurements by radioimmunoassay of bone gla protein in the plasma of normal subjects and patients with bone disease. J. Clin. Invest. 66:878-883.
45. Price, P. A., M. K. Williamson, and J. W. Lothringer. 1981. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J. Biol. Chem. 256:12760-12766.
46. Rauch, F., E. Schonau, H. Woitge, T. Remer, and M. Seibel. 1994. Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children. Exp. Clin. Endocrinol. 102:94-97.
47. Robins, S. P., P. Stewart, C. Astbury, and H. A. Bird. 1986. Measurement of the cross-linking compound, pyridinoline, in urine as an index of collagen degradation. Ann. Rheum. Dis. 45: 969-973.
48. Saggese, G., I. Baroncelli, S. Bertelloni, L. Cinquanta, and G. DiNero. 1994. Twenty-four-hour osteocalcin. Carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children. Pediatr. Res. 35:409-415.
49. SAS. 1989. SAS-STAT® User's Guide (Version 6, 4th Ed.). SAS Inst. Inc., Cary, NC.
50. SAS. 1997. SAS-STAT Software, Changes and Enhancements through Release 6.12. SAS Inst. Inc., Cary, NC.
51. Schlemmer, A., C. Hassager, S. B. Jensen, and C. Christiansen. 1992. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J. Clin. Endocrinol. Metab. 74:476-480.
52. Schlemmer, A., C. Hassager, B. J. Pedersen, and C. Christiansen. 1994. Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. J. Bone Miner. Res. 9:1883-1888.
53. Seibel, M. J., and H.A.P. Pols. 1996. Clinical application of biochemical markers of bone metabolism. In: J. P. Bilezikian, L. G. Raisz, and G. A. Rodan (Ed.) Principles of Bone Biology. pp 1293-1311. Academic Press, San Diego, CA.